You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Claims for Patent: 8,607,785


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,607,785
Title:Systems and devices for generating nitric oxide
Abstract: Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.
Inventor(s): Fine; David H. (Cocoa, FL), Johnson; Bryan (Merritt Island, FL), Vasquez; Gregory (Cocoa, FL)
Assignee: Geno LLC (Cocoa, FL)
Application Number:12/541,137
Patent Claims: 1. A device for generating nitric oxide from nitrogen dioxide, comprising: a body including an inlet, an outlet and a diverter; and a porous solid matrix positioned within the body and a space between the body and the porous solid matrix, wherein the porous solid matrix includes a thermoplastic resin and silica gel, wherein the porous solid matrix is coated with an antioxidant, and wherein the inlet is configured to receive a gas flow, the diverter directs the gas flow to the space between the body and the porous solid matrix, and the gas flow is fluidly communicated to the outlet through the porous solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide.

2. The device of claim 1, further comprising a humidifier in communication with the inlet of the body.

3. The device of claim 1, wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

4. The device of claim 1, wherein the density of the silica gel is similar to the density of the thermoplastic resin.

5. The device of claim 1, wherein the porous solid matrix comprises at least 20% silica gel.

6. The device of claim 1, wherein the porous solid matrix comprises approximately 20% to approximately 60% silica gel.

7. A system for delivering nitric oxide to a patient, comprising: a gas source of nitrogen dioxide, dinitrogen tetraoxide, or nitric oxide; a first device having a body including an inlet, an outlet, a diverter, a porous solid matrix including a thermoplastic resin and silica gel and a space between the body and the porous solid matrix, wherein the porous solid matrix is coated with an antioxidant and the porous solid matrix is positioned between the inlet and the outlet, wherein the inlet is configured to receive a gas flow from the source, the diverter directs the gas flow to the space between the body and the porous solid matrix, and the gas flow is fluidly communicated to the outlet through the porous solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide; and a patient interface coupled to the outlet of the first device, the patient interface delivering nitric oxide to the patient.

8. The system of claim 7, further comprising a humidifier positioned between the gas source and the first device.

9. The system of claim 8, wherein the humidifier is integral with the first device.

10. The system of claim 7, further comprising a humidifier positioned prior to the patient interface.

11. The system of claim 8, further comprising: a second humidifier positioned after the first device; and a second device positioned after a second humidifier, the second device comprising an inlet, an outlet, and a porous solid matrix coated with an antioxidant, wherein the inlet is configured to receive a gas flow from the first device and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide.

12. The system of claim 7, wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

13. The device of claim 1, wherein the space is between the inlet and the porous solid matrix.

14. The system of claim 7, wherein the space is between the inlet and the porous solid matrix.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.